1Cvitkovic E. A historical perspective on Oxaliplatin: rethinking the role of platinum compounds and learing from near misses[J]. Semin Oncol, 1998,2502 ( Suppl 57 ): 1-3
2Bleiberg H. Oxaliplatin (L-OHP): a new reality in colorectal cancer[J]. Br J cancer,1998,77 (Suppl 4): 1-3.
3Becouarin Y, Rongier P . Clinical efficacy of Oxaliplatin monotherapy: phase Ⅱ trials in advanced colorectal cancer[ J].Semin Oncol, 1998,25 ( Suppl 5 ) :23-31.
4Beliberg H, de Granont A. Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer [ J ].Semin Oncol, 1998,2592( Suppl 5 ) :32-39.
5Ducreux M,, Louvet C, Bekradda N, et al. Oxaliplatin for the treatment of advanced colorectal cancer: future directions [ J ].Semin Oncol, 1998,25 ( Suppl 5 ) :47-53.
6Raymond E, Feivre M, Waynaroushi JM, et al. Oxaliplatin:mechanism of action and anti neoplastic activity [ J ] . Semin Oncol, 1998,25 ( Suppl 5 ) :4-12.
7Extra JM,Marty M, Brienza S,et al. Pharmacokinetics and safety profile on Oxaliplatin [ J ]. Semin Oncol, 1998,25 ( Suppl 5 ): 13-22.
4Tashiro AJ,Moore CW. Accu mulation of cis-diammine dichloroplatinum(Ⅱ) and platinum analogues by platinrm resistant murine leukemia cells invitro[J]. Cancer Res,1998,48(1):9-13
5周际昌．实用肿瘤内科学[M]．第1版．北京：人民卫生出版社，1998：205-297．
6Dillman RO, Herndon J, Searren SL, et al . Improved survival in stage 3 non- small cell lung cancer:seven year follow- up of cancer and leudemia group B(CALGB) 8 433 trial [J].J Natal Cancer Inst, 1996,88(17):1 210-1 216.
7贾博琦，鲁云兰．现代临床使用药物手册[M]．第2版．北京：北京医科大学出版社，2001：2．
8贾博琦.现代临床使用药物手册[M].2版.北京:北京医科大学出版社,2001:21.
9Xiao J,Cai Z,Li W,et al.Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone:Results from a Prospective Trial[J].J Cancer,2015,6(7):636-642.
